Tag: Carcinoid Cancer Foundation

Happy 4th of July from The Carcinoid Cancer Foundation

Advocacy Award Honors the Late Monica Warner of the Carcinoid Cancer Foundation: Call for Nominations

Novartis Oncology has announced its 2010 Warner Advocacy Award named in honor of Monica Warner, a driving force behind the Carcinoid Cancer Foundation for two decades and an extraordinary advocate for carcinoid and neuroendocrine tumor patients. …

Proclamation Heralds Worldwide Neuroendocrine Tumor (NET) Cancer Awareness Day: November 10, 2010

To raise greater awareness of neuroendocrine tumor (NET) cancers the first annual Worldwide NET Cancer Awareness Day is being planned for Wednesday, November 10, 2010.  In preparation for this unique day, a proclamation has been created by the World…

Study to Evaluate Families with History of Carcinoid Cancer

The Natural History of Familial Carcinoid Tumor is recruiting participants who are interested in being part of a study that will “evaluate families with a history of carcinoid cancer to determine ways to improve early detection and to find the gene that…

YMCA/Rocky Gap Triathlon in Maryland Supports Carcinoid Cancer Foundation

Thanks to the extraordinary generosity of the Cumberland YMCA in Maryland, the YMCA/Rocky Gap Triathlon, and a carcinoid patient and her family, the Carcinoid Cancer Foundation is one of three charitable organizations being supported by the June 5,…

Clinical Trial Recruiting Neuroendocrine Tumor Patients with Pheochromocytoma or Paraganglioma

Neuroendocrine tumor patients with malignant pheochromocytoma or paraganglioma are being sought for a multi-center clinical trial conducted by Molecular Insight Pharmaceuticals, Inc. In the New York area, one of the clinical trial sites is the Mount…

Carcinoid Cancer Foundation Presents Symposium on Cutting-Edge Treatment

Determining Molecular Signature:  A Guide for Targeted Therapy of Neuroendocrine Tumors

Imagine a treatment created just for you as a carcinoid or other neuroendocrine tumor patient based upon a personalized genomic analysis.  This is the cutting-edge…

Steve Jobs, Pancreatic Neuroendocrine Tumor Patient, Talks about Liver Transplant

Steve Jobs, CEO of Apple, is the most well-known member of the carcinoid and neuroendocrine tumor community. He was diagnosed with an islet cell pancreatic neuroendocrine tumor (NET) in 2004 for which he had surgery, followed by a liver transplant in …

Worldwide Neuroendocrine Tumor (NET) Cancer Awareness Day: November 10, 2010

An extraordinary, first of its kind event is planned for November 10, 2010: Worldwide NET (neuroendocrine tumor) Cancer Awareness Day.  Leaders of carcinoid/NET patient support and advocacy groups from throughout the world have been brought together…

Carcinoid Cancer Foundation Thanks Silja Chouquet

During a recent meeting in Berlin of the international Steering Committee for Worldwide NET Cancer Awareness Day (WNCAD) on November 10, 2010, Grace Goldstein of the Carcinoid Cancer Foundation had the opportunity to hear a fascinating presentation…